Karine Breckpot

mRNA based cancer vaccination


Vrije Universiteit Brussel

Brussels – Belgium


Karine Breckpot has completed her PhD on genetically engineered dendritic cell vaccines in 2004 at the VUB (Belgium) and continued this line of research during her postdoctoral studies performed at VUB (Belgium) and the University College London (UK).

She is a tenure track professor at the VUB, member of the faculty and research board, and president of the ethical committee for use of laboratory animals.

She is a recognized expert in the field of immunotherapy as evidenced by her list of publications, patents, invited lectures, awards and presence in grant review committees.